Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 47

    1.

    Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.

    Sugimoto K, Moriyasu F, Shiraishi J, Saito K, Taira J, Saguchi T, Imai Y.

    Eur Radiol. 2012 Jun;22(6):1205-13. Epub 2012 Jan 24.

    PMID:
    22270142
    [PubMed - in process]
    2.

    Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study.

    Sieghart W, Pinter M, Reisegger M, Müller C, Ba-Ssalamah A, Lammer J, Peck-Radosavljevic M.

    Eur Radiol. 2012 Jun;22(6):1214-23. Epub 2012 Jan 4.

    PMID:
    22215073
    [PubMed - in process]
    3.

    Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis.

    Ishibashi H, Maruyama H, Takahashi M, Shimada T, Kamesaki H, Fujiwara K, Imazeki F, Yokosuka O.

    Eur Radiol. 2012 May;22(5):1083-90. Epub 2011 Dec 30.

    PMID:
    22207268
    [PubMed - in process]
    Free PMC Article
    4.

    Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.

    Collettini F, Schnapauff D, Poellinger A, Denecke T, Schott E, Berg T, Wust P, Hamm B, Gebauer B.

    Eur Radiol. 2012 May;22(5):1101-9. Epub 2011 Dec 16.

    PMID:
    22173693
    [PubMed - in process]
    5.

    Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis.

    Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES.

    Eur Radiol. 2012 May;22(5):1075-82. Epub 2011 Dec 4.

    PMID:
    22138733
    [PubMed - in process]
    6.

    Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT.

    Higashihara H, Osuga K, Onishi H, Nakamoto A, Tsuboyama T, Maeda N, Hori M, Kim T, Tomiyama N.

    Eur Radiol. 2012 Apr;22(4):872-9. Epub 2011 Nov 26.

    PMID:
    22120061
    [PubMed - in process]
    7.

    Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.

    Ippolito D, Capraro C, Casiraghi A, Cestari C, Sironi S.

    Eur Radiol. 2012 Apr;22(4):803-11. Epub 2011 Nov 16.

    PMID:
    22086560
    [PubMed - in process]
    8.

    Effects of microperfusion in hepatic diffusion weighted imaging.

    Dijkstra H, Baron P, Kappert P, Oudkerk M, Sijens PE.

    Eur Radiol. 2012 Apr;22(4):891-9. Epub 2011 Nov 12.

    PMID:
    22080250
    [PubMed - in process]
    Free PMC Article
    9.

    Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT.

    Onishi H, Kim T, Imai Y, Hori M, Nagano H, Nakaya Y, Tsuboyama T, Nakamoto A, Tatsumi M, Kumano S, Okada M, Takamura M, Wakasa K, Tomiyama N, Murakami T.

    Eur Radiol. 2012 Apr;22(4):845-54. Epub 2011 Nov 7.

    PMID:
    22057248
    [PubMed - in process]
    10.

    Letter to the editor re: contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100).

    Frauscher F.

    Eur Radiol. 2011 Nov;21(11):2311-2; author reply 2313-4. Epub 2011 Jun 23. No abstract available.

    PMID:
    21698464
    [PubMed - indexed for MEDLINE]
    11.

    Integrative role of MRI in the evaluation of primary biliary cirrhosis.

    Kovač JD, Ješić R, Stanisavljević D, Kovač B, Banko B, Seferović P, Maksimović R.

    Eur Radiol. 2012 Mar;22(3):688-94. Epub 2011 Oct 12.

    PMID:
    21989789
    [PubMed - indexed for MEDLINE]
    12.

    Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.

    Dahlqvist Leinhard O, Dahlström N, Kihlberg J, Sandström P, Brismar TB, Smedby O, Lundberg P.

    Eur Radiol. 2012 Mar;22(3):642-53. Epub 2011 Oct 9.

    PMID:
    21984449
    [PubMed - indexed for MEDLINE]
    13.

    Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history.

    Marin D, Galluzzo A, Plessier A, Brancatelli G, Valla D, Vilgrain V.

    Eur Radiol. 2011 Oct;21(10):2074-82. Epub 2011 Jun 28.

    PMID:
    21710271
    [PubMed - indexed for MEDLINE]
    14.

    The added value of contrast-enhanced ultrasound in patients with colorectal cancer undergoing preoperative evaluation with extensive gadobenate dimeglumine liver MRI.

    Kartalis N, Brismar TB, Mihocsa L, Isaksson B, Albiin N.

    Eur Radiol. 2011 Oct;21(10):2067-73. Epub 2011 May 27.

    PMID:
    21617893
    [PubMed - indexed for MEDLINE]
    15.

    Hepatic and pancreatic involvement in hereditary hemorrhagic telangiectasia: quantitative and qualitative evaluation with 64-section CT in asymptomatic adult patients.

    Barral M, Sirol M, Placé V, Hamzi L, Borsik M, Gayat E, Boudiaf M, Soyer P.

    Eur Radiol. 2012 Jan;22(1):161-70. Epub 2011 Aug 23.

    PMID:
    21861188
    [PubMed - indexed for MEDLINE]
    16.

    Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression.

    Tsuda N, Matsui O.

    Eur Radiol. 2011 Dec;21(12):2542-50. Epub 2011 Aug 11.

    PMID:
    21830099
    [PubMed - indexed for MEDLINE]
    17.

    Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival.

    Bouvier A, Ozenne V, Aubé C, Boursier J, Vullierme MP, Thouveny F, Farges O, Vilgrain V.

    Eur Radiol. 2011 Aug;21(8):1719-26. Epub 2011 Apr 12.

    PMID:
    21479978
    [PubMed - indexed for MEDLINE]
    18.

    Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100).

    Correas JM, Low G, Needleman L, Robbin ML, Cosgrove D, Sidhu PS, Harvey CJ, Albrecht T, Jakobsen JA, Brabrand K, Jenett M, Bates J, Claudon M, Leen E.

    Eur Radiol. 2011 Aug;21(8):1739-46. Epub 2011 Apr 10.

    PMID:
    21479856
    [PubMed - indexed for MEDLINE]
    19.
    20.

    The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging.

    Kitao A, Matsui O, Yoneda N, Kozaka K, Shinmura R, Koda W, Kobayashi S, Gabata T, Zen Y, Yamashita T, Kaneko S, Nakanuma Y.

    Eur Radiol. 2011 Oct;21(10):2056-66. Epub 2011 May 29.

    PMID:
    21626360
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk